ERT Medicines
Supply of ERT medicines to NHS Scotland: NP92615 (a) Laronidase - Aldurazyme® NP92615 (b) Imiglucerase - Cerezyme® NP92615 (c) Agalsidase Beta - Fabrazyme® NP92615 (d) Alglucosidase Alfa - Myozyme®
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£4,011,280
Published
24 May 2023
Closes
24 May 2023
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 ERT Medicines
£4,011,280
The Framework Agreements are for the supply of ERT Medicines to NHS Scotland. The Framework Agreements have been awarded as single supplier framework agreements per line to one (1) Framework Participant.
Delivery: Scotland
Documents
Unlock document linkERT Medicines
Not provided
Supply of ERT medicines to NHS Scotland: NP92615 (a) Laronidase - Aldurazyme® NP92615 (b) Imiglucerase - Cerezyme® NP92615 (c) Agalsidase Beta - Fabrazyme® NP92615 (d) Alglucosidase Alfa - Myozyme®
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.